Jonathan Douxfils

Jonathan Douxfils is a recognized expert in the fields of pharmacology and laboratory diagnostics, currently serving as a Board Member of the Belgian Society on Thrombosis and Haemostasis since May 2024. As the CEO/Founder and President of the Board at QUALIblood since November 2017, Jonathan Douxfils also holds positions as a Professor and Director of the Research Unit in Clinical Pharmacology and Toxicology at Université de Namur, where coursework includes pharmacology and pharmaceutical technologies. Additionally, Jonathan Douxfils is involved with several editorial and advisory roles, including positions on the editorial boards of Frontiers in Pharmacology and JTH, and as a committee chair for F.R.S. - FNRS. Educationally, Jonathan Douxfils earned a PhD in Pharmaceutical and Biomedical Sciences from Université de Namur and holds multiple degrees in pharmaceutical sciences from prestigious institutions.